Prosecution Insights
Last updated: July 17, 2026
Application No. 18/644,201

REGIONAL RESOLUTION IN FAST ANATOMICAL MAPPING

Non-Final OA §102§103
Filed
Apr 24, 2024
Priority
Dec 16, 2020 — divisional of 12/070,277
Examiner
NGUYEN, VI X
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Biosense Webster (Israel) Ltd.
OA Round
1 (Non-Final)
86%
Grant Probability
Favorable
1-2
OA Rounds
1y 0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 86% — above average
86%
Career Allowance Rate
999 granted / 1163 resolved
+15.9% vs TC avg
Moderate +13% lift
Without
With
+13.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
35 currently pending
Career history
1193
Total Applications
across all art units

Statute-Specific Performance

§101
0.5%
-39.5% vs TC avg
§103
64.0%
+24.0% vs TC avg
§102
28.3%
-11.7% vs TC avg
§112
1.7%
-38.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1163 resolved cases

Office Action

§102 §103
DETAILED ACTION Claim Interpretation The following is a quotation of 35 U.S.C. 112(f): (f) Element in Claim for a Combination. – An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The following is a quotation of pre-AIA 35 U.S.C. 112, sixth paragraph: An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The claims in this application are given their broadest reasonable interpretation using the plain meaning of the claim language in light of the specification as it would be understood by one of ordinary skill in the art. The broadest reasonable interpretation of a claim element (also commonly referred to as a claim limitation) is limited by the description in the specification when 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is invoked. As explained in MPEP § 2181, subsection I, claim limitations that meet the following three-prong test will be interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph: (A) the claim limitation uses the term “means” or “step” or a term used as a substitute for “means” that is a generic placeholder (also called a nonce term or a non-structural term having no specific structural meaning) for performing the claimed function; (B) the term “means” or “step” or the generic placeholder is modified by functional language, typically, but not always linked by the transition word “for” (e.g., “means for”) or another linking word or phrase, such as “configured to” or “so that”; and (C) the term “means” or “step” or the generic placeholder is not modified by sufficient structure, material, or acts for performing the claimed function. Use of the word “means” (or “step”) in a claim with functional language creates a rebuttable presumption that the claim limitation is to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites sufficient structure, material, or acts to entirely perform the recited function. Absence of the word “means” (or “step”) in a claim creates a rebuttable presumption that the claim limitation is not to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is not interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites function without reciting sufficient structure, material or acts to entirely perform the recited function. Claim limitations in this application that use the word “means” (or “step”) are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. Conversely, claim limitations in this application that do not use the word “means” (or “step”) are not being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1-3, 7 is/are rejected under 35 U.S.C. 102(a)(1) as anticipated by or, in the alternative, under 35 U.S.C. 103 as obvious over Guttman et al U.S 2010/0312096. Claim 1: Guttman et al disclose a method for improving regional resolution in fast anatomical mapping as best seen in figures 10,12-13, comprising: receiving, on a surface of an anatomical map 32 of a patient organ having a first presentation, a selection of a first selected region, which is intended to have a second presentation different from the first presentation (see paragraphs 105, 140); identifying (i) a perimeter of the first selected region, and (ii) at least an unselected area positioned within the first selected region (see fig. 15, paragraph 139); Note that other embodiments are directed to MRI guided cardiac interventional systems. The systems include: a display; a processor in communication with the display and adapted to communicate with a MRI scanner; electronic memory coupled to the processor; and computer program code residing in the memory that is executable by the processor for: [0011] (a) generating at least one near real time (RT) MRI image of at least a portion of a heart of a patient using relevant anatomical scan planes associated with a 3-D MRI image space having a coordinate system; [0012] (b) identifying coordinates associated with a location of at least a distal portion of at least one flexible intrabody catheter in the 3-D MRI image space to track a location of a distal end portion of the catheter; [0013] (c) rendering dynamic near RT visualizations of the at least one flexible catheter in the 3-D image space, wherein the at least one flexible catheter is not required to be in any of the relevant anatomical scan planes used to obtain MR data for the at least one near RT MRI image, and wherein the distal end portion of the flexible catheter can take on a non-linear shape; [0014] (d) displaying a graphical user interface (GUI) containing at least one of the visualizations within the display; and [0015] (e) allowing a user to alter the visualizations using the GUI to selectively show different tissue characteristic maps or data from the selected tissue characteristic map (see paragraph 10, claim 65). Alternatively, it would have been obvious that the above description of Guttman et al steps would produce a second selected region, comprising (i) the first selected region, and (il) the unselected area; and displaying the anatomical map having the second presentation applied to the second selected region. Thus, claim 1 is unpatentable over Guttman et al. Claims 2-3, 7: Guttman et al disclose wherein the first presentation comprises a first mapping resolution of the anatomical map and the second presentation comprises a second mapping resolution of the second selected region of the anatomical map (see paragraph 134)., wherein the first selected region comprises one or more selected areas and at least the unselected area, wherein identifying the unselected area comprises identifying, within the first selected region, at least an isolated unselected area surrounded by the one or more selected areas (see paragraph 139); wherein the first selected region comprises first and second selected areas at least partially disjoint from one another by the unselected area, wherein identifying the unselected area comprises identifying, within the first selected region, the unselected area that is partially enclosed by the first and second selected areas (see paragraphs 134,139). Allowable Subject Matter Claims 4-6,8-10 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to VI X NGUYEN whose telephone number is (571)272-4699. The examiner can normally be reached Monday-Friday (6:30-4:30). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Darwin Erezo can be reached at 571-272-4695. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /VI X NGUYEN/Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Apr 24, 2024
Application Filed
Oct 02, 2025
Non-Final Rejection mailed — §102, §103
Dec 17, 2025
Response Filed
Apr 07, 2026
Request for Continued Examination
Apr 21, 2026
Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12678278
Tunable Fixation Device
2y 8m to grant Granted Jul 14, 2026
Patent 12672953
HANDLING DEVICE WITH INCREASED FUNCTIONALITY FOR HAIR TRANSPLANTATION OPERATIONS AND SURGICAL PROCEDURE
2y 4m to grant Granted Jul 07, 2026
Patent 12667350
METHOD AND SYSTEM FOR USE IN A LUNG ACCESS PROCEDURE TO AID IN PREVENTING PNEUMOTHORAX
2y 1m to grant Granted Jun 30, 2026
Patent 12661190
SYSTEMS AND METHODS FOR FACILITATING MOVEMENT EFFICIENCY OF A MEDICAL DEVICE WITHIN A BODILY CAVITY
2y 6m to grant Granted Jun 23, 2026
Patent 12661195
Surgical Robot and Method for Displaying Image of Patient Placed on Surgical Table
1y 10m to grant Granted Jun 23, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
86%
Grant Probability
99%
With Interview (+13.3%)
3y 3m (~1y 0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1163 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month